Delayed cardiac toxicity from anthracycline therapy. Academic Article uri icon

Overview

abstract

  • Survivors of childhood cancer who received anthracycline treatment have a high incidence of abnormal cardiac function. Cardiac decompensation and death can appear many years after completion of chemotherapy. These survivors require periodic evaluation of cardiac function and rhythm.

publication date

  • January 1, 1991

Research

keywords

  • Arrhythmias, Cardiac
  • Daunorubicin
  • Doxorubicin
  • Heart
  • Heart Failure

Identity

Scopus Document Identifier

  • 0025917514

PubMed ID

  • 1983861

Additional Document Info

volume

  • 18

issue

  • 1